의약품 관련 법령
ANVISA News: New System for the Notification of Adverse Events with Medicinal Products and Vaccines to be Launched in December
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-12-04 | 조회수 | 833 |
| 국가정보 | 남 아메리카>브라질 | ||
| 출처 | ANVISA | ||
| 원문 | http://www.anvisa.gov.br/ | ||
| 첨부파일 | |||
New System for the Notification of Adverse Events with Medicinal Products and Vaccines to be Launched in December.pdf(57.11KB)
ANVISA informs that it will launch on 10-Dec-2018 the new Vigimed system, for the notification of adverse events for medicinal products and vaccine, which is an adapted version of the VigiFlow system from the World Health Organization.
ANVISA clarifies that the new system will replace the one in use, the Notivisa system, only for the notification of adverse events in medicinal products and vaccines...
ANVISA clarifies that the new system will replace the one in use, the Notivisa system, only for the notification of adverse events in medicinal products and vaccines...
- 이전글 ANMAT-MED-BED 010-00: Guide for Scale Variations and Variations for Substances Subjected to the Demonstration of Bioequivalence
- 다음글 Public Consultation 572: Revocation of Obsolete Norms
